Autres langues XWELL, Inc.

Actions

XWEL

US98420U8027

Temps Différé Nasdaq Autres places de cotation 17:20:37 03/06/2024			Varia. 5j.	Varia. 1 janv.
1,63 ^USD	+4,49 %		-2,40 %	-6,32 %

23/05	XWELL, Inc. prévoit d'introduire le masseur thermique thérapeutique Ceragem V6 dans certains établissements Xpresspa	CI
15/05	XWELL, Inc. annonce ses résultats pour le premier trimestre clos le 31 mars 2024	CI

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

XWELL, Inc. Plans to Introduce the Ceragem V6 Therapeutic Thermal Massager in Select Xpresspa Locations	23/05
XWELL, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	15/05
XWELL, Inc. Introduces IV Hydration Drip Therapy at Miami International Airport	02/05
XWELL, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	16/04
Transcript : XWELL, Inc., 2023 Earnings Call, Apr 16, 2024	16/04
XWELL, Inc. Signs Leases to Open Three Additional Naples Wax Center Locations in the Southeastern Part of the United States	14/02
XWELL, Inc. Elects Gaëlle S. Wizenberg as Member of the Audit Committee and the Compensation Committee	02/02
XWELL Announces Plans to Open an XpresSpa in The Penn District	04/01
XWELL, Inc. Announces Board Changes, Effective January 1, 2024	15/12
XWELL, Inc. Introduces Clockwork Robotic Manicures At Harry Reid International Airport in Las Vegas	11/12
XWELL, Inc. Opens New XpresSpa Location in Abu Dhabi International Airport	15/11
XWELL, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	14/11
US CDC to expand surveillance of traveler samples for respiratory viruses	06/11
Ginkgo Bioworks, XWELL Expand CDC Program Partnership to Test for More Than 30 Pathogens	06/11
US CDC to expand surveillance of travelers for respiratory viruses	06/11
Transcript : XWELL, Inc. - Special Call	04/10/23
Reverse Split: 1 for 20	28/09/23	FA
XWELL, Inc. acquired Naples Wax Center, Inc. for $1.6 million.	12/09/23
XWELL, Inc. Extends Collaboration with Centers for Disease Control and Prevention?s Traveler-Based Genomic Surveillance Program	17/08/23
XWELL, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	14/08/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues XWELL, Inc.

Actions

XWEL

US98420U8027

Autres langues

Filtres